CliniSys Group Creates Single Brand for UK and Europe

CliniSys GroupCliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website.

The move creates a unified identity for CliniSys in the UK and MIPS on the continent and underlines the group's commitment to providing end-to-end diagnostic systems to support safe and effective healthcare systems today and to drive medical innovation in the future.

Chair and chief executive Michael Simpson said: "The CliniSys Group is the largest diagnostic laboratory IT vendor in Europe. Our combined cross-discipline expertise, spanning more than 40 years, provides our customers with solutions that span the diagnostic journey.

"We have reached this position by following our core values: customer, promises, simplicity and teamwork - a commitment to providing customers with the best possible products, services and support. From late March, we have a new look but our values remain steadfast, and we look forward to continuing to care for our customers while working with them on the innovative solutions that we will all need for the future."

In the UK, CliniSys is known for its laboratory information management system which is installed in over 50% of NHS pathology laboratories. Tests for more than 40 million patients are processed on its order communications system every year with over 70% of NHS acute trusts using ICE for GP electronic requesting.

In October 2015, CliniSys was acquired by Roper Technologies and this has enabled it to add systems from complementary suppliers, such as Sunquest Information Systems and Data Innovations. This has enabled CliniSys to offer its UK customers industry-leading, end-to-end solutions, and to think creatively about meeting the needs of pathology networks, integrated care systems, and the coming world of precision medicine.

The CliniSys name is being retained in the UK, although the logo has been refreshed. Richard Craven, CliniSys chief executive, said: "Increasingly, CliniSys and MIPS have been working more collaboratively, launching common products such as our Genomics solution and developing our Cloud architecture and strategy. We have been one company for many years, and we felt now is the right time to bring our 40 year pedigree, track record and product proposition of the CliniSys Group together in one place and under one brand."

In Europe, MIPS is best known for its general laboratory information management system or GLIMS. This is the most widely used LIMS on the continent, where it is relied on by 15,000 people operating in 17 countries and ten languages.

MIPS also has a history of innovation. It has developed GLIMS Genomics as a LIMS to meet the needs of new, high-tech genetics laboratories, and seen it successfully deployed in Poitiers University Hospital. CliniSys recently brought GLIMS Genomics to the UK, which is developing its own network of genomic laboratory hubs.

CliniSys | MIPS will be the new brand for MIPS across Europe.

Alongside its new identity, CliniSys has launched a new website with information about its products, case studies highlighting the great work being done by its customers, and blogs about the development of pathology and diagnostic laboratory IT.

The website is at: www.clinisysgroup.com. There are no changes to the group's contracts, support services, product roadmap or release schedule.

About CliniSys Group

CliniSys Group is the largest laboratory diagnostic IT vendor in Europe, with leading country market shares and an innovative and wide-reaching suite of end-to-end diagnostic solutions.

Headquartered in England, with local offices in six European countries, it has for more than 40 years been at the forefront of diagnostics workflow, order communications and information management solutions supporting radiology, cardiology and all pathology disciplines including anatomical or cellular, molecular and genetics.

These encompass the complete workflow from order, clinical decision support, collection, processing, analysis, results and reporting, through integration into the clinical workflow. CliniSys Group has built an unrivalled reputation for the deployment of complex diagnostics networks and academic centres - and is the only vendor repeatably delivering across all disciplines end to end - at scale.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...